Drug Target Review

JUNE 11, 2025

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.

Drugs 64

Drugs Clinical Trials Drug Development Pharmaceuticals 64

The Pharma Data

OCTOBER 27, 2020

License-related fees (5). License-related fees (5). The BREEZE study (NCT03950739) seeks to evaluate 45 patients on a stable dose of Tyvaso after switching to our new dry powder inhaler (DPI) form of treprostinil, which we licensed from MannKind Corporation. .

FDA 40

FDA Production Licensing Licensing 40

Drug Target Review

APRIL 11, 2025

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Geukes Foppen RJ, Gioia V, Zoccoli A, Velez CN.

Clinical Development 97

Clinical Development Drugs Pharmaceuticals Clinical Trials 97

Drug Target Review

MARCH 13, 2025

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Connect on LinkedIn >> Literature Explainambiguity: When What You Think Is Not What You Get [Internet].

Drug Development 59

Drug Development Science Clinical Trials Drugs 59

Drug Target Review

FEBRUARY 11, 2025

Managing this data deluge requires the expertise of multidisciplinary fields like clinical bioinformatics , which bridges statistics, biology and computer science. He also develops and presents customised training programmes (both live and virtual) for companies seeking to improve their in- and out-licensing processes.

Drug Development 59

Drug Development Bioinformatics Drugs Small Molecule 59